SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-004506
Filing Date
2024-06-27
Accepted
2024-06-27 07:31:10
Documents
15
Period of Report
2024-06-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm   iXBRL 8-K 31845
2 OPINION sonoma_ex0501.htm EX-5.1 11157
6 GRAPHIC image_001.jpg GRAPHIC 4976
  Complete submission text file 0001683168-24-004506.txt   227683

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snoa-20240627.xsd EX-101.SCH 3027
4 XBRL LABEL FILE snoa-20240627_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE snoa-20240627_pre.xml EX-101.PRE 22367
18 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3667
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 241075385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)